Selectis Health Announces Board and Officer Changes
Ticker: GBCS · Form: 8-K · Filed: Oct 1, 2024 · CIK: 727346
| Field | Detail |
|---|---|
| Company | Selectis Health, Inc. (GBCS) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $150,000, $250,000, $7,500 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, management-change, 8-k
TL;DR
Selectis Health (SLHS) filed an 8-K for board/officer changes on Oct 1st.
AI Summary
On October 1, 2024, Selectis Health, Inc. (formerly Global Healthcare REIT, Inc.) filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information on the election of new directors and the appointment of certain officers, along with details regarding their compensatory arrangements.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate governance changes and does not involve significant financial transactions or operational disruptions.
Key Players & Entities
- SELECTIS HEALTH, INC. (company) — Registrant
- GLOBAL HEALTHCARE REIT, INC. (company) — Former Company Name
- GLOBAL CASINOS INC (company) — Former Company Name
- MORGRO CHEMICAL CO (company) — Former Company Name
- October 1, 2024 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors and executive officers of Selectis Health, Inc. on October 1, 2024?
The 8-K filing indicates the election of directors and the appointment of certain officers, along with details on their compensatory arrangements, but does not list specific names or roles within this summary.
What was Selectis Health, Inc. previously known as?
Selectis Health, Inc. was formerly known as Global Healthcare REIT, Inc., and prior to that, Global Casinos Inc and Morgro Chemical Co.
In which state is Selectis Health, Inc. incorporated?
Selectis Health, Inc. is incorporated in Utah.
What is the business address of Selectis Health, Inc.?
The business address is 8480 E. Orchard Road, Suite 4900, Greenwood Village, CO 80111.
What is the SIC code for Selectis Health, Inc.?
The Standard Industrial Classification (SIC) code for Selectis Health, Inc. is 6798, which corresponds to Real Estate Investment Trusts.
Filing Stats: 373 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-10-01 16:55:29
Key Financial Figures
- $150,000 — ef Executive Officer, Adam Desmond from $150,000 to $250,000 per annum, payable weekly.
- $250,000 — Officer, Adam Desmond from $150,000 to $250,000 per annum, payable weekly. Upon effecti
- $7,500 — Company's Board Compensation stipend of $7,500 quarterly. SIGNATURE Pursuant to the
Filing Documents
- form8-k.htm (8-K) — 30KB
- 0001493152-24-039043.txt ( ) — 197KB
- gbcs-20241001.xsd (EX-101.SCH) — 3KB
- gbcs-20241001_lab.xml (EX-101.LAB) — 33KB
- gbcs-20241001_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number (I.R.S. Employer Identification number) 8480 E. Orchard Road , Ste. 4900 , Greenwood Village , CO 80111 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (720) 680-0808 (Former name or former address, if changed since last report) Written communications pursuant to Rule 425 under the Securities Act Soliciting material pursuant to Rule 14a-12 under the Exchange Act Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Securities registered pursuant to Section 12(b) of the Act: Title of each Class Trading Symbol Name of each exchange on which registered N/A N/A N/A Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS Effective October 1, 2024, the Board of Directors of Selectis Health, Inc. (the "Company"), approved of a salary increase for the Chief Executive Officer, Adam Desmond from $150,000 to $250,000 per annum, payable weekly. Upon effectiveness of the salary increase Mr. Desmond has agreed to forgo the Company's Board Compensation stipend of $7,500 quarterly. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Selectis Health, Inc. (Registrant) Dated: October 1, 2024 /s/ James Creamer, III James Creamer, III, CFO